Immunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival

doi:10.12998/wjcc.v5.i6.247

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5796)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

342

WORD

289

HTML

2574

Figures (1-3)

201

Tables (1-2)

190

Sum=3596

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

855

Download

1345

Sum=2200

Jun 16, 2017 (publication date) through Jul 5, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jun 16, 2017; 5(6): 247-253
Published online Jun 16, 2017. doi: 10.12998/wjcc.v5.i6.247

Full Size Figure Download Figure

Figure 2 Immunofluorescence based immuno-histochemistry analysis and interpretation for human telomerase reverse transcriptase and high mobility group-A1: Control sample showed negative expression of both markers; intense immune-reactivity of high mobility group-A1 and human telomerase reverse transcriptase in Glioblastoma-multiforme and moderate expression in our case.

Citation: Gandhi P, Khare R, Garg N, Sorte S. Immunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival. World J Clin Cases 2017; 5(6): 247-253
URL: https://www.wjgnet.com/2307-8960/full/v5/i6/247.htm
DOI: https://dx.doi.org/10.12998/wjcc.v5.i6.247